Page last updated: 2024-11-02

pd 169316 and Dementias, Transmissible

pd 169316 has been researched along with Dementias, Transmissible in 1 studies

2-(4-nitrophenyl)-4-(4-fluorophenyl)-5-(4-pyridinyl)-1H-imidazole: p38 MAP kinase inhibitor

Research Excerpts

ExcerptRelevanceReference
"Prion diseases are neurodegenerative pathologies characterized by the accumulation in the brain of a protease-resistant form of the prion protein (PrP(c)), named PrP(Sc)."1.31p38 MAP kinase mediates the cell death induced by PrP106-126 in the SH-SY5Y neuroblastoma cells. ( Arena, S; Benatti, U; Corsaro, A; Damonte, G; Florio, T; Millo, E; Schettini, G; Tagliavini, F; Thellung, S; Villa, V, 2002)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Thellung, S1
Villa, V1
Corsaro, A1
Arena, S1
Millo, E1
Damonte, G1
Benatti, U1
Tagliavini, F1
Florio, T1
Schettini, G1

Other Studies

1 other study available for pd 169316 and Dementias, Transmissible

ArticleYear
p38 MAP kinase mediates the cell death induced by PrP106-126 in the SH-SY5Y neuroblastoma cells.
    Neurobiology of disease, 2002, Volume: 9, Issue:1

    Topics: Amino Acid Chloromethyl Ketones; Apoptosis; Caspase 3; Caspases; Cysteine Proteinase Inhibitors; Enz

2002